Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ICU | Common Stock, par value $0.0001 per share | Award | $0 | +33.8K | +4.8% | $0.00 | 736K | Aug 31, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | ICU | Stock Option (Right to Buy) | 99.7K | Aug 31, 2023 | Common Stock | 99.7K | $1.84 | Direct | F2 | |||||
holding | ICU | Stock Option (Right to Buy) | 18K | Aug 31, 2023 | Common Stock | 18K | $10.00 | Direct | F3 | |||||
holding | ICU | Stock Option (Right to Buy) | 84K | Aug 31, 2023 | Common Stock | 84K | $0.53 | Direct | F4 |
Id | Content |
---|---|
F1 | The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. Due to an administrative error, the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently overstated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1,428 shares. This error has been corrected on this Form 4. |
F2 | All options reported herein will vest, subject to continued service, on April 6, 2024, the first anniversary of the date of grant. |
F3 | These options are fully vested. |
F4 | The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from February 20, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from February 20, 2021. |